Home/Filings/4/0001415889-25-019776
4//SEC Filing

Liebert Debra K. 4

Accession 0001415889-25-019776

CIK 0001408443other

Filed

Jul 14, 8:00 PM ET

Accepted

Jul 15, 4:15 PM ET

Size

11.2 KB

Accession

0001415889-25-019776

Insider Transaction Report

Form 4
Period: 2025-07-11
Transactions
  • Award

    Series B Common Warrants (right to buy)

    2025-07-11+16,79316,793 total
    Exercise: $1.88Exp: 2030-07-11Common Shares (16,793 underlying)
  • Award

    Common Shares

    2025-07-11+16,66616,793 total
  • Award

    Series A Common Warrants (right to buy)

    2025-07-11+16,79316,793 total
    Exercise: $1.50Exp: 2026-07-11Common Shares (16,793 underlying)
Holdings
  • Common Shares

    (indirect: By Trust)
    10,000
  • Common Shares

    (indirect: By Trust)
    4,000
Footnotes (3)
  • [F1]The reported securities are included within 16,793 Issuer Units purchased by the Reporting Person for $1.50 per Unit. Each Unit consists of one common share, one Series A common warrant and one Series B common warrant, each warrant represents the right to purchase 16,793 shares of common stock.
  • [F2]These shares are held in a trust for the benefit of several including the Reporting Person's spouse. The Reporting Person's spouse is a co-executor of the trust. The Reporting Person disclaims beneficial ownership of these securities, and the filing of this report is not an admission that the Reporting Person is the beneficial owner of these securities for purposes of Section 16 or for any other purpose.
  • [F3]Fully vested and exercisable.

Issuer

Milestone Pharmaceuticals Inc.

CIK 0001408443

Entity typeother

Related Parties

1
  • filerCIK 0001772891

Filing Metadata

Form type
4
Filed
Jul 14, 8:00 PM ET
Accepted
Jul 15, 4:15 PM ET
Size
11.2 KB